Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Ordinary Shares Nominal value of NIS 0.0000769 per share
-
Shares outstanding
-
45.5M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
10.2M
-
Shares change
-
-11.3K
-
Total reported value, excl. options
-
$19.4M
-
Value change
-
+$12.9K
-
Number of buys
-
9
-
Number of sells
-
-6
-
Price
-
$1.90
Significant Holders of Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share (ENTX) as of Q2 2025
24 filings reported holding ENTX - Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share as of Q2 2025.
Entera Bio Ltd. - Ordinary Shares Nominal value of NIS 0.0000769 per share (ENTX) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.2M shares
of 45.5M outstanding shares and own 22.44% of the company stock.
Largest 10 shareholders include Knoll Capital Management, LLC (5.88M shares), Point72 Asset Management, L.P. (2.7M shares), Schonfeld Strategic Advisors LLC (605K shares), Parkman Healthcare Partners LLC (356K shares), NORTHERN TRUST CORP (201K shares), BESSEMER GROUP INC (141K shares), HighTower Advisors, LLC (67.5K shares), RENAISSANCE TECHNOLOGIES LLC (64.3K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (48.9K shares), and SIGNATURE ESTATE & INVESTMENT ADVISORS LLC (47.3K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.